CD44 and ovarian carcinoma: One recent report tested a dendrimer-based drug delivery system for carrying paclitaxel and siRNA targeted to CD44 mRNA while another constructed PLGA nanoparticles with short hairpin RNA (shRNA) against focal adhesion kinase (FAK) and CD44 for enhancing antitumor effects in an ovarian cancer mouse xenograph [90,91].